Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma

Journal of Investigative Surgery

Volumn 26, Issue 6, 2013, Pages 352-359

  Nikfarjam, Mehrdad ^a   Yeo, Dannel ^a   He, Hong ^a   Baldwin, Graham ^a   Fifis, Theodora ^a   Costa, Patricia ^a   Tan, Bryan ^a   Yang, Eunice ^a   Wen, Shu W ^a   Christophi, Christopher ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Animal models; Metastatic neoplasm; Pancreatic neoplasm

Indexed keywords

MATRIGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; HISTOLOGY; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; MALE; MOUSE; MURINE MODEL; NONHUMAN; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; NEOPLASM TRANSPLANTATION; PANCREAS; PANCREATIC NEOPLASMS;

EID: 84887888638     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2013.797057     Document Type: Article

References (23)

1. Vincent A, Herman J, Schulick R, et al. Pancreatic cancer. Lancet. 2011;378:607-620
2. JemalA, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300
3. Winter JM, Brennan MF, Tang LH, et al. Survival after resection of pancreatic adenocarcinoma: Results from a single institution over three decades. Ann Surg Oncol. 2012;19:169-175
4. Hoffman RM. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic. Invest New Drugs. 1999;17:343-359
5. Erkan M, Hausmann S, Michalski CW, et al. The role of stroma in pancreatic cancer: Diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol. 2012;9: 454-467
6. Li X, Ma Q, Xu Q, et al. Targeting the cancer-stroma interaction: A potential approach for pancreatic cancer treatment. Curr Pharm Des. 2012;18:2404-2415
7. Capella G, Farre L, Villanueva A, et al. Orthotopic models of human pancreatic cancer. Ann N Y Acad Sci. 1999;880:103-109
8. Fogh J, Orfeo T, Tiso J, et al. Twenty-three new human tumor lines established in nude mice. Exp Cell Biol. 1980;48:229-239
9. Ding Y, Cravero JD, Adrian K, et al. Modeling pancreatic cancer in vivo: From xenograft and carcinogeninduced systems to genetically engineered mice. Pancreas. 2010;39:283-292
10. Olive KP, Tuveson DA. The use of targeted mouse models for preclinical testing of novel cancer therapeutics. Clin Cancer Res. 2006;12:5277-5287
11. Hassanin H, Serba S, Schmidt J, et al. Ex vivo expanded telomerase-specific T cells are effective in an orthotopic mouse model for pancreatic adenocarcinoma. Clin Exp Immunol. 2009;158:125-132
12. Hotz HG, Hines OJ, Foitzik T, et al. Animal models of exocrine pancreatic cancer. Int J Colorectal Dis. 2000;15:136-143
13. Westphalen CB, Olive KP. Genetically engineered mouse models of pancreatic cancer. Cancer J. 2012;18: 502-510
14. SchmidtM, Deschner EE, Thaler HT, et al. Gastrointestinal cancer studies in the human to nude mouse heterotransplant system. Gastroenterology. 1977;72:829-837
15. Dineen SP, Sullivan LA, Beck AW, et al. The Adnectin CT- 322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer. BMC Cancer. 2008;8:352
16. Partecke LI, SendlerM,Kaeding A, et al.Asyngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines. Eur Surg Res. 2011;47:98-107
17. Fidler IJ. Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst. 1995;87:1588-1592
18. Tseng WW, Winer D, Kenkel JA, et al. Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. Clin Cancer Res. 2010;16:3684-3695
19. Bibby MC. Orthotopic models of cancer for preclinical drug evaluation: Advantages and disadvantages. Eur J Cancer. 2004;40:852-857
20. Partecke IL, Kaeding A, Sendler M, et al. In vivo imaging of pancreatic tumours and liver metastases using 7 TeslaMRI in a murine orthotopic pancreatic cancer model and a liver metastases model. BMC Cancer. 2011;11:40
21. Ishizu K, Sunose N, Yamazaki K, et al. Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells. Biol Pharm Bull. 2007;30:1779-1783
22. Marincola FM, Drucker BJ, Siao DY, et al. The nude mouse as amodel for the study of human pancreatic cancer. J Surg Res. 1989;47:520-529
23. Alves F, Contag S, Missbach M, et al. An orthotopic model of ductal adenocarcinoma of the pancreas in severe combined immunodeficient mice representing all steps of the metastatic cascade. Pancreas. 2001;23:227-235